Daaks (uk) Limited

POWER SEARCH PRICING

SOLUTIONS

daaks (uk) limited Company Information

Company Number

06408886

Next Accounts

Mar 2025

Directors

Manishkumar Vibhakar

Jignasha Vibhakar

Shareholders

krish pharma ltd

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

73 grove road, walthamstow, E17 9BU

Website

daaks (uk) limited Estimated Valuation

£610.9k

Pomanda estimates the enterprise value of DAAKS (UK) LIMITED at £610.9k based on Net Assets of £292.6k and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Daaks (uk) Limited is a live company located in walthamstow, E17 9BU with a Companies House number of 06408886. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 2007, it's largest shareholder is krish pharma ltd with a 100% stake. Daaks (uk) Limited is a established, small sized company, Pomanda has estimated its turnover at £581.8k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Daaks (Uk) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

3 Strong

4 Regular

5 Weak

Size

annual sales of £581.8k, make it smaller than the average company (£11.9m)

Growth

3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (6.5%)

EXPORT

Daaks (Uk) Limited's latest turnover from June 2023 is estimated at £581.8 thousand and the company has net assets of £292.6 thousand. According to their latest financial statements, Daaks (Uk) Limited has 6 employees and maintains cash reserves of £73.8 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	581,782	659,988	761,136	631,572	641,760	1,327,096	396,132	510,752	693,305	726,674	847,216	869,833	1,031,994	971,916
Other Income Or Grants
Cost Of Sales	393,733	438,818	514,842	436,401	438,343	891,576	266,478	346,982	483,871	503,367	589,763	615,902	725,925	676,440
Gross Profit	188,049	221,170	246,294	195,171	203,417	435,520	129,654	163,770	209,435	223,307	257,453	253,931	306,069	295,476
Admin Expenses	217,023	257,444	281,675	217,985	233,479	456,838	71,389	147,517	196,441	110,577	129,800	187,505	205,182	175,595
Operating Profit	-28,974	-36,274	-35,381	-22,814	-30,062	-21,318	58,265	16,253	12,994	112,730	127,653	66,426	100,887	119,881
Interest Payable		845	1,447	950	236
Interest Receivable	3,663	808	58	50	153	195	296	772	990	1,015	502	391	416	126
Pre-Tax Profit	-25,311	-36,311	-36,770	-23,714	-30,146	-21,123	58,560	17,025	13,984	113,745	128,155	66,818	101,303	120,007
Tax							-11,126	-3,405	-2,937	-26,161	-30,757	-17,373	-28,365	-33,602
Profit After Tax	-25,311	-36,311	-36,770	-23,714	-30,146	-21,123	47,434	13,620	11,047	87,584	97,398	49,445	72,938	86,405
Dividends Paid
Retained Profit	-25,311	-36,311	-36,770	-23,714	-30,146	-21,123	47,434	13,620	11,047	87,584	97,398	49,445	72,938	86,405
Employee Costs	153,850	191,102	180,750	127,531	126,661	223,292	75,817	88,089	103,683	120,589	117,967	117,247	135,126	134,140
Number Of Employees	6	8	8	6	6	11	4	5	6	7	7	7	8	8
EBITDA*	3,589	-3,212	-2,137	10,924	-30,062	-21,318	81,399	16,253	42,876	145,074	155,347	95,852	123,745	142,858

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	4,841	6,390	6,690	8,171	10,335	401,988	1,900	480	22,148	29,530	15,584	20,778	1,073	1,431
Intangible Assets	234,583	265,597	296,610	327,624	358,638		412,152	264,375	292,500	315,000	337,500	360,000	382,500	405,000
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	239,424	271,987	303,300	335,795	368,973	401,988	414,052	264,855	314,648	344,530	353,084	380,778	383,573	406,431
Stock & work in progress	43,602	38,305	35,571	34,830	34,540		31,500	32,500	30,500	28,500	30,500	34,500	33,750	32,150
Trade Debtors	54,660	53,552	88,249	90,208	86,013	159,290	48,500	85,419	92,250	80,182	109,241	117,170	101,289	86,863
Group Debtors
Misc Debtors	13,286	15,316	16,320	13,921	7,407		12,485
Cash	73,799	72,710	56,552	59,232	40,734		78,035	158,395	150,294	245,645	160,465	40,470	115,991	50,447
misc current assets
total current assets	185,347	179,883	196,692	198,191	168,694	159,290	170,520	276,314	273,044	354,327	300,206	192,140	251,030	169,460
total assets	424,771	451,870	499,992	533,986	537,667	561,278	584,572	541,169	587,692	698,857	653,290	572,918	634,603	575,891
Bank overdraft				2,750	7,007
Bank loan
Trade Creditors	81,987	83,340	80,456	79,674	77,908	116,530	86,637	58,874	173,554	286,981	335,763	347,641	474,945	489,086
Group/Directors Accounts	22,977	20,219	16,858	14,918	18,597		13,711	35,343
other short term finances
hp & lease commitments
other current liabilities	26,291	29,190	23,882	22,729	19,453		17,713	27,875
total current liabilities	131,255	132,749	121,196	120,071	122,965	116,530	118,061	122,092	173,554	286,981	335,763	347,641	474,945	489,086
loans			23,307	21,374
hp & lease commitments
Accruals and Deferred Income
other liabilities									7,990	16,001	8,125	12,234
provisions	920	1,214	1,271	1,553			540	540	1,231	2,005	3,116	4,155	215	300
total long term liabilities	920	1,214	24,578	22,927			540	540	9,221	18,006	11,241	16,389	215	300
total liabilities	132,175	133,963	145,774	142,998	122,965	116,530	118,601	122,632	182,775	304,987	347,004	364,030	475,160	489,386
net assets	292,596	317,907	354,218	390,988	414,702	444,748	465,971	418,537	404,917	393,870	306,286	208,888	159,443	86,505
total shareholders funds	292,596	317,907	354,218	390,988	414,702	444,748	465,971	418,537	404,917	393,870	306,286	208,888	159,443	86,505

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-28,974	-36,274	-35,381	-22,814	-30,062	-21,318	58,265	16,253	12,994	112,730	127,653	66,426	100,887	119,881
Depreciation	1,549	2,049	2,230	2,724			634		7,382	9,844	5,194	6,926	358	477
Amortisation	31,014	31,013	31,014	31,014			22,500		22,500	22,500	22,500	22,500	22,500	22,500
Tax							-11,126	-3,405	-2,937	-26,161	-30,757	-17,373	-28,365	-33,602
Stock	5,297	2,734	741	290	34,540	-31,500	-1,000	2,000	2,000	-2,000	-4,000	750	1,600	32,150
Debtors	-922	-35,701	440	10,709	-65,870	98,305	-24,434	-6,831	12,068	-29,059	-7,929	15,881	14,426	86,863
Creditors	-1,353	2,884	782	1,766	-38,622	29,893	27,763	-114,680	-113,427	-48,782	-11,878	-127,304	-14,141	489,086
Accruals and Deferred Income	-2,899	5,308	1,153	3,276	19,453	-17,713	-10,162	27,875
Deferred Taxes & Provisions	-294	-57	-282	1,553		-540		-691	-774	-1,111	-1,039	3,940	-85	300
Cash flow from operations	-5,332	37,890	-1,665	6,520	-17,901	-76,483	113,308	-69,817	-88,330	100,079	123,602	-61,516	65,128	479,629
Investing Activities
capital expenditure		-1,749	-749	-560	33,015	12,064	-172,331	49,793		-23,790		-26,631		-429,408
Change in Investments
cash flow from investments		-1,749	-749	-560	33,015	12,064	-172,331	49,793		-23,790		-26,631		-429,408
Financing Activities
Bank loans
Group/Directors Accounts	2,758	3,361	1,940	-3,679	18,597	-13,711	-21,632	35,343
Other Short Term Loans
Long term loans		-23,307	1,933	21,374
Hire Purchase and Lease Commitments
other long term liabilities								-7,990	-8,011	7,876	-4,109	12,234
share issue					100	-100								100
interest	3,663	-37	-1,389	-900	-83	195	296	772	990	1,015	502	391	416	126
cash flow from financing	6,421	-19,983	2,484	16,795	18,614	-13,616	-21,336	28,125	-7,021	8,891	-3,607	12,625	416	226
cash and cash equivalents
cash	1,089	16,158	-2,680	18,498	40,734	-78,035	-80,360	8,101	-95,351	85,180	119,995	-75,521	65,544	50,447
overdraft			-2,750	-4,257	7,007
change in cash	1,089	16,158	70	22,755	33,727	-78,035	-80,360	8,101	-95,351	85,180	119,995	-75,521	65,544	50,447

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for daaks (uk) limited. Get real-time insights into daaks (uk) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for daaks (uk) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in E17 area or any other competitors across 12 key performance metrics.

DAAKS (UK) LIMITED group structure

Daaks (Uk) Limited has no subsidiary companies.

Ultimate parent company

KRISH PHARMA LTD

10300834

1 parent

DAAKS (UK) LIMITED

06408886

DAAKS (UK) LIMITED Shareholders

krish pharma ltd

100%

Daaks (Uk) Limited currently has 2 directors. The longest serving directors include Mr Manishkumar Vibhakar (Nov 2016) and Mrs Jignasha Vibhakar (Mar 2018).

officer	country	age	start	end	role
Mr Manishkumar Vibhakar	United Kingdom	53 years	Nov 2016	-	Director
Mrs Jignasha Vibhakar	United Kingdom	49 years	Mar 2018	-	Director

P&L

June 2023

turnover

581.8k

-12%

operating profit

-29k

gross margin

32.4%

-3.55%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

292.6k

-0.08%

total assets

424.8k

-0.06%

cash

73.8k

+0.01%

net assets

Total assets minus all liabilities

Similar Companies

woodside (london) limited

uk apothecary limited

2.5

v.n.r.s. limited

maneph resources limited

4.5

premson limited

company number

06408886

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

October 2007

ultimate parent company

KRISH PHARMA LTD

previous names

N/A

address

73 grove road, walthamstow, E17 9BU

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to daaks (uk) limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for DAAKS (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.

daaks (uk) limited Company Information

daaks (uk) limited Estimated Valuation

daaks (uk) limited Estimated Valuation

daaks (uk) limited Estimated Valuation

Daaks (uk) Limited Overview

Daaks (uk) Limited Health Check

DAAKS (UK) LIMITED financials

daaks (uk) limited Credit Report and Business Information

Daaks (uk) Limited Competitor Analysis

daaks (uk) limited Ownership

daaks (uk) limited directors

daaks (uk) limited company details

daaks (uk) limited Charges & Mortgages

daaks (uk) limited Capital Raised & Share Issues BETA

daaks (uk) limited Companies House Filings - See Documents